See more : Cambi ASA (CAMBI.OL) Income Statement Analysis – Financial Results
Complete financial analysis of Flower One Holdings Inc. (FONE.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Flower One Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Emeco Holdings Limited (EOHDF) Income Statement Analysis – Financial Results
- ESH Acquisition Corp. (ESHA) Income Statement Analysis – Financial Results
- Semler Scientific, Inc. (SMLR) Income Statement Analysis – Financial Results
- AC Immune SA (ACIU) Income Statement Analysis – Financial Results
- Immunotech Laboratories, Inc. (IMMB) Income Statement Analysis – Financial Results
Flower One Holdings Inc. (FONE.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.flowerone.com
About Flower One Holdings Inc.
Flower One Holdings Inc. engages in the cultivation and production of medical and recreational cannabis. It owns and operates 400,000 square foot greenhouse for cannabis cultivation and 55,000 square foot cannabis production facility in Nevada; and 25,000 square-feet indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, packages, and wholesales dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, beverages, topicals, and infused products. It provides cannabis products under the NLVO brand name. The company sells its products directly to dispensaries, as well as engages in the contract cultivation, production, and packaging for consumer cannabis brands. Flower One Holdings Inc. is based in Vancouver, Canada.
| Metric | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58.36M | 34.24M | 9.48M | 130.97K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 36.99M | 74.58M | -21.18M | -306.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 21.37M | -40.34M | 30.66M | 437.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 36.62% | -117.80% | 323.48% | 334.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 22.66M | 18.68M | 17.50M | 8.11M | 141.25K | 138.24K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 646.99K | 609.66K | 667.65K | 183.21K | -6.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 23.31M | 19.29M | 18.17M | 8.29M | 134.93K | 138.24K | 118.53K | 223.55K | 275.54K | 147.17K | 106.35K | 110.54K | 68.70K | 56.32K |
| Other Expenses | 11.59M | 8.07M | 3.69M | 75.19K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 34.90M | 27.36M | 21.86M | 8.37M | 134.93K | 0.00 | 118.53K | 276.27K | 283.95K | 147.17K | 106.35K | 110.54K | 68.70K | 56.32K |
| Cost & Expenses | 71.88M | 101.94M | 676.93K | 8.06M | 141.25K | 138.24K | 118.53K | 276.27K | 283.95K | 147.17K | 106.35K | 110.54K | 68.70K | 56.32K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 29.18 | 626.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 22.13M | 26.26M | 14.00M | 0.00 | 29.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 6.33M | 48.44M | 1.42M | 75.19K | 2.28K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -7.20M | -59.08M | 10.22M | -7.22M | -138.96K | -136.11K | -118.51K | -276.18K | -283.08K | -146.67K | -106.35K | -110.54K | -68.70K | -56.32K |
| EBITDA Ratio | -12.33% | -172.52% | 107.85% | -5,509.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -13.53M | -107.51M | 8.80M | -7.93M | -141.25K | -136.11K | -118.51K | -276.18K | -283.08K | -146.67K | -106.35K | -110.54K | -68.70K | -56.32K |
| Operating Income Ratio | -23.18% | -313.97% | 92.86% | -6,055.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -10.92M | -15.11M | -3.97M | -4.44M | 9.50K | 0.00 | -368.69K | 199.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -24.45M | -122.62M | 4.83M | -12.37M | -131.75K | 0.00 | -487.20K | -76.98K | -283.08K | 0.00 | -106.35K | -110.54K | 0.00 | 0.00 |
| Income Before Tax Ratio | -41.89% | -358.10% | 50.98% | -9,447.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 21.33M | -5.15M | 4.31M | 76.11K | -9.52K | 0.00 | 0.00 | 0.00 | 0.00 | 146.67K | 0.00 | -39.79K | 68.70K | 56.32K |
| Net Income | -45.78M | -117.47M | 524.96K | -12.45M | -131.75K | 0.00 | -487.20K | -76.98K | -283.08K | -146.67K | -106.35K | -70.75K | -68.70K | -56.32K |
| Net Income Ratio | -78.45% | -343.05% | 5.54% | -9,506.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.12 | -0.51 | 0.00 | -0.09 | -0.06 | 0.00 | -0.25 | -0.05 | -0.20 | -0.11 | -0.09 | -0.07 | -0.25 | -0.26 |
| EPS Diluted | -0.12 | -0.51 | 0.00 | -0.09 | -0.06 | 0.00 | -0.25 | -0.05 | -0.20 | -0.11 | -0.09 | -0.07 | -0.25 | -0.26 |
| Weighted Avg Shares Out | 384.06M | 231.27M | 180.11M | 138.19M | 2.12M | 0.00 | 1.93M | 1.40M | 1.38M | 1.28M | 1.23M | 982.26K | 280.00K | 215.84K |
| Weighted Avg Shares Out (Dil) | 384.06M | 231.27M | 180.11M | 138.19M | 2.12M | 0.00 | 1.93M | 1.40M | 1.38M | 1.28M | 1.23M | 982.26K | 280.00K | 215.84K |
Source: https://incomestatements.info
Category: Stock Reports